Literature DB >> 12734418

Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc.

Zoë A Felton-Edkins1, Niall S Kenneth, Timothy R P Brown, Nicole L Daly, Natividad Gomez-Roman, Carla Grandori, Robert N Eisenman, Robert J White.   

Abstract

The synthesis of tRNA and 5S rRNA by RNA polymerase (pol) III is cell cycle regulated in higher organisms. Overexpression of pol III products is a general feature of transformed cells. These observations may be explained by the fact that a pol III-specific transcription factor, TFIIIB, is strongly regulated by the tumor suppressors RB and p53, as well as the proto-oncogene product c-Myc. RB and p53 repress TFIIIB, but this restraint can be lost in tumors through a variety of mechanisms. In contrast, c-Myc binds and activates TFIIIB, causing potent induction of pol III transcription. Using chromatin immunoprecipitation and RNA interference, we show that c-Myc interacts with tRNA and 5S rRNA genes in transformed cervical cells, stimulating their expression. Availability of pol III products may be an important determinant of a cell's capacity to grow. The ability to regulate pol III output may therefore be integral to the growth control functions of RB, p53 and c-Myc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734418

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  54 in total

1.  Search for basonuclin target genes.

Authors:  Junwen Wang; Shengliang Zhang; Richard M Schultz; Hung Tseng
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

2.  Chromatin structure analyses identify miRNA promoters.

Authors:  Fatih Ozsolak; Laura L Poling; Zhengxin Wang; Hui Liu; X Shirley Liu; Robert G Roeder; Xinmin Zhang; Jun S Song; David E Fisher
Journal:  Genes Dev       Date:  2008-11-15       Impact factor: 11.361

3.  Regulation of TFIIIB during F9 cell differentiation.

Authors:  Dimitris Athineos; Lynne Marshall; Robert J White
Journal:  BMC Mol Biol       Date:  2010-03-12       Impact factor: 2.946

4.  Involvement of RNA Polymerase III in Immune Responses.

Authors:  Damian Graczyk; Robert J White; Kevin M Ryan
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

5.  Essential roles of Raf/extracellular signal-regulated kinase/mitogen-activated protein kinase pathway, YY1, and Ca2+ influx in growth arrest of human vascular smooth muscle cells by bilirubin.

Authors:  Marlon Stoeckius; Anna Erat; Tatsuya Fujikawa; Makoto Hiromura; Anna Koulova; Leo Otterbein; Cesario Bianchi; Edda Tobiasch; Yossi Dagon; Frank W Sellke; Anny Usheva
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 6.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

Review 7.  MYC regulation of cell growth through control of transcription by RNA polymerases I and III.

Authors:  Kirsteen J Campbell; Robert J White
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

8.  Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases.

Authors:  Tharakeswari Selvakumar; Alison Gjidoda; Stacy L Hovde; R William Henry
Journal:  J Biol Chem       Date:  2012-01-04       Impact factor: 5.157

9.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

10.  Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.

Authors:  William W Lockwood; Raj Chari; Bradley P Coe; Kelsie L Thu; Cathie Garnis; Chad A Malloff; Jennifer Campbell; Ariane C Williams; Dorothy Hwang; Chang-Qi Zhu; Timon P H Buys; John Yee; John C English; Calum Macaulay; Ming-Sound Tsao; Adi F Gazdar; John D Minna; Stephen Lam; Wan L Lam
Journal:  PLoS Med       Date:  2010-07-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.